In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

According to a new market research report, 'Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis ...

a minimal residual disease (MRD) detection solution showcasing a limit of detection (LOD) down to one-in-a-million. MRDVision combines Inocras’s WGS cancer profiling platform, CancerVision ...

Foresight Diagnostics, a privately-held cancer diagnostics company based in Aurora, Colorado, USA, has developed a novel liquid biopsy testing platform, PhasED-Seq, that allows detection of MRD ...

Adaptive Biotechnologies get expanded medicare coverage of clonoSEQ for assessing measurable residual disease in mantle cell lymphoma: Seattle Saturday, November 9, 2024, 15:00 Hr ...

Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...

Littelfuse’s RCMP20 residual current monitors support compact, high-current Mode 2 and Mode 3 EV charging stations.

A dozen cruise ship passengers were sickened by Legionnaires’ disease — including 10 who were hospitalized — on two different ...

Unaware of the leak, the children entered first and did not recognize the distinct odor of mercaptan, the additive that gives ...

a minimal residual disease (MRD) detection solution showcasing a limit of detection (LOD) down to one-in-a-million. MRDVision combines Inocras’s WGS cancer profiling platform, CancerVision, and Ultima ...

SEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCLCoverage leverages new Medicare episode pricing ...